Sustained and selective attention as measures of genetic liability to schizophrenia

Schizophrenia Research

Volumn 48, Issue 2-3, 2001, Pages 263-272

  Jones, L A ^a   Cardno, A G ^a   Sanders, R D ^a   Owen, M J ^a   Williams, J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Attention; Continuous performance test; Negative priming; Schizophrenia liability

Indexed keywords

CHLORPROMAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSAGE FORM; FEMALE; GENETIC HETEROGENEITY; HOSPITALIZATION; HUMAN; INTELLIGENCE TEST; MALE; MEDICAL LIABILITY; MENTAL HEALTH; NEGATIVE SYNDROME; ONSET AGE; PRIORITY JOURNAL; RELATIVE; SCHIZOPHRENIA; SELECTIVE ATTENTION; SIGNAL DETECTION; STIMULUS RESPONSE; SYMPTOMATOLOGY; TASK PERFORMANCE;

ADOLESCENT; ADULT; ATTENTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION (PSYCHOLOGY);

EID: 0035970654     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00136-5     Document Type: Article

References (62)

1. An attentional assessment of foster children at risk for schizophrenia
2. Residual performance deficit in clinically remitted schizophrenics: A marker of schizophrenia?
3. Individual differences in negative priming: Relations with schizotypal personality traits
4. Evidence of reduced 'cognitive inhibition' in schizophrenia
5. Individual differences in schizotypy as reflected in measures of cognitive inhibition
6. Individual differences in cognitive processes: Towards an explanation of schizophrenic symptomatology
7. The multidimensional nature of schizotypal traits: A factor analytic study with normal subjects
8. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers
9. Dimensions of psychosis in affected sibling pairs
10. Lateralization of the 'negative priming' effect: Relationships with schizotypy and with gender
11. Schizotypy and lateralised negative priming in schizophrenics' and neurotics' relatives
12. Schizotypal personality disorder in individuals with and without schizophrenic relatives: Similarities and contrasts in neurocognitive and clinical functioning
13. The Continuous Performance Test, Identical Pairs Version (CPT-IP): I. New findings about sustained attention in normal families
14. The Continuous Performance Test, Identical Pairs Version: II. Contrasting attentional profiles in schizophrenic and depressed patients
15. The New York High Risk Project: A follow-up report
16. Attentional abilities and measures of schizotypy: Their variation and covariation in schizophrenic patients, their siblings and normal control subjects
17. Neuropsychological assessment of monozygotic twins discordant for schizophrenia
18. Familial prevalence and coaggregation of schizotypy indicators: A multitrait family study
19. Attentional markers of vulnerability to schizophrenia: Performance of medicated and unmedicated patients and normals
20. Information-processing markers of vulnerability to schizophrenia: Performance of patients with schizotypal and nonschizotypal personality disorders
21. Complete multipoint sib-pair analysis of qualitative and quantitative traits
22. Inhibition through negative priming with Stroop stimuli in schizophrenia
23. Schizotypy and sustained attention
24. The symptoms of chronic schizophrenia: A re-examination of the positive and negative dichotomy
25. Analysis of the attention deficit in schizophrenia: A study of patients and their relatives in Ireland
26. Reduced cognitive inhibition in schizotypy
27. Signal detection in vigilance tasks and behavioural attributes among offspring of schizophrenic mothers and among hyperactive children
28. Visual sustained attention: Image degradation produces rapid sensitivity decrement over time
29. Converging evidence for vigilance deficit as a vulnerability indicator for schizophrenic disorders
30. Attentional vulnerability indicators, thought disorder, and negative symptoms
31. Vigilance in schizophrenia and related disorders. Neuropsychology, psychophysiology, and information processing
32. Testing vulnerability models: Stability of potential vulnerability indictors across clinical states
33. Psychometric schizotypy and sustained attention in young males
34. Attention dysfunction in chronic schizophrenia
35. The effects of daily carphenazine on attention in the schizophrenic patient
36. Sustained attention and positive formal thought disorder in schizophrenia
37. Attentional inhibition in schizophrenia and schizotypy
38. Cognitive inhibition and positive symptomatology in schizotypy
39. Sustained attention in children at risk for schizophrenia: Report on continuous performance test
40. Sustained attention in children at risk for schizophrenia: Findings with two visual continuous performance tests in a new sample
41. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics
42. Vulnerabilities to schizophrenia: Information processing markers
43. 'Cognitive inhibition' and schizotypy as measured by the Oxford-Liverpool Inventory of Feelings and Experiences
44. Electrophysiological and behavioural signs of attentional disturbance in schizophrenics and their siblings
45. The negative priming effect: Inhibitory priming by ignored objects
46. Spatial negative priming without mismatching: Comment on Park and Kanwisher (1994)
47. Attentional and neuromotor functions of schizophrenics, schizoaffectives and patients with other affective disorders
48. Further evidence for a multi-dimensional personality disposition to schizophrenia in terms of cognitive inhibition
49. Cognitive inhibition and schizophrenic symptom subgroups
50. SCAN: Schedules for Clinical Assessment in Neuropsychiatry
51. Sustained attention in remitted schizophrenics